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Background and experimental approach
A main challenge in cell therapies and other tissue
regeneration approaches is to produce a therapeutically
significant cell number. For expansion of mesenchymal
stem cells (MSC) the cultivation on 2D plastic surfaces
is still the conventional procedure, even though the
culture conditions differ significantly from the 3D
environment in vivo. Additionally, static amplification
of MSC is a labour-intensive procedure. We therefore
used a specialized rotating bed bioreactor in order to
maximize ex vivo expansion of MSC. MSC were iso-
lated from umbilical cord (UC) by explant method
approach under xeno-free conditions. UC-MSC were
thereafter expanded under dynamic conditions in a
novel rotating bed bioreactor. The bioreactor system
was designed to enable integration of sensors for online
monitoring of various parameters (e.g. pH, pO2, pCO2)
and hence, allow ensured cultivation under well con-
trolled and reproducible conditions. Beside cell expan-
sion, directed differentiation of MSC was also achieved
in bioreactors. MSC lack the ability to grow in 3D
direction and build functional tissue in vitro. Thus, it is
necessary to seed and culture MSC on 3D matrices to
obtain functional implants. For guided differentiation
towards the osteogenic lineage, MSC were cultivated
on ceramic porous matrices under dynamic conditions.
Custom-made miniaturized perfusion bioreactors for
parallel testing were designed and optimized for that
purpose.
Methods
MSC isolation was achieved as described previously [1].
Briefly, umbilical cord tissue is cut into pieces (approx.
0.5 cm2) and cultivated for 10 days in aMEM containing
15% human serum in cell culture flasks. Cells grow out
of the tissue pieces and adhere to the cell culture plastic.
Subsequently, cells are harvested and subcultivated in
aMEM containing 10% human serum.
UC-MSC were expanded in a rotating bed bioreactor
(Figure 1A). The bioreactor chamber is a cylindrical
bioreactor shell, comprising an inlet (bed) fixed to a
magnet whereas the bioreactor chamber is hold by that
magnet to an engine. The inlay is rotating, while the
shell is fixed. The inlay comprises cell culture plastic
slides with an all over surface of 2000 cm2, requiring
approximately 130 ml cell culture medium to be com-
pletely covered. The bioreactor is equipped with a feed
circulation for fresh medium and removal of waste. An
additional circulation to pH and pO2 sensor electrodes
enables online monitoring. Sampling is performed
through a septum in the bioreactor shell. Gas mixture
of air and CO2 is supplied by an overlay stream. The
whole bioreactor set up is situated in a GMP conform
breeder, enabling sterile handling as well as an environ-
mental temperature of 38°C. The system is connected to
a control unit, which comprises gas regulation, pumps
and software for parameter set up and monitoring. UC-
MSC were seeded (1,500 cells/cm2) in the bioreactor for
24 h hours and expanded for 5 days under dynamic
conditions. Medium feed was adjusted depending on
glucose consumption. After 5 days of cultivations UC-
MSC were harvested by flushing the bioreactor with
accutase for 20 min. MSC were counted, examined
regarding their senescence (b-galactosidase), proli-
feration capacity (glucose/lactate) and differentiation
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potential (Oil Red O, Alizarin Red, Von Kossa, Alcian
Blue), as well as surface markers.
Perfusion bioreactors consist of a stainless steel tube
in which the material is inserted and a piston, which
closes the reactors (Figure 1B). As the piston can be
adjusted in height a bioreactor can host materials with a
diameter of 10 mm and a high of max. 10 mm. MSC-
seeded ceramic materials (10 mm × 3 mm) were
inserted into the bioreactor. The bioreactors are con-
nected to a medium reservoir, equipped with a sterile
filter for gas exchange. The volume of the bioreactor
containing the ceramic material is 1,5 ml, the overall
volume of medium used for the cultivation is 10 ml.
Dynamic cultivation was achieved using flow rates of 0.3
and 1.5 ml/min. Viability was examined using MTT
Assay. Cell distribution throughout the scaffold was
investigated using DAPI staining. The status of differen-
tiation was examined using different histological stain-
ings (e.g. Von Kossa, Calcein, Alizarin Red).
Results and discussion
UC-MSC isolated using explant method approach fulfils
MSC criteria, such as adherence to plastic surfaces, spe-
cific surface marker pattern and differentiation potential
towards at least the adipogenic, chondrogenic and
osteogenic lineage [1].
MSC expanded under dynamic conditions in a rotat-
ing bed bioreactor also fulfil these MSC criteria.
Furthermore it could be shown, that MSC consume
glucose and produce lactate during dynamic cultivation
in the rotating bed bioreactor and consequently prolifer-
ate. After 5 days of cultivation MSC were investigated
regarding their specific surface marker. They express
CD44, CD73, CD90 and CD 105 and lack CD 31, CD34
and CD45.
MSC on ceramic materials could be shown to differ-
entiate towards the osteogenic lineage under static con-
ditions. Also after dynamic cultivation with a medium
perfusion of 0.3 ml/min and even 1.5 ml/min cells
adhere on the macro porous ceramic material, were
viable and equally distributed throughout the scaffold.
Seeding efficiency was found to be approximately 20%.
Osteogenic differentiation could be achieved by cultiva-
tion in perfusion bioreactors.
Conclusion
MSC could be successfully isolated from human umbili-
cal cord tissue. MSC expansion in the rotation bed bior-
eactor provides a high number of cells, maintaining
their stem cell properties such as specific surface mar-
kers, proliferation capacity and differentiation potential.
Cultivation of MSC in perfusion bioreactors have been
shown to support and improve osteogenic differentiation
as mechanical plays an important role in directing MSC
fate. Our results support the argument that the applica-
tion of tailor-made bioreactors are an essential step
toward the production of stem cell based therapeutics
and tissue engineering products.
Figure 1 A) Rotation bed bioreactor for expansion of MSC and B) Perfusion bioreactors.
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